Preview

Nephrology and Dialysis

Advanced search

Hemodiafiltration: attention on the volume Review

Abstract

In the review the data supporting the efficiency of on-line hemodiafiltration regarding hard outcomes are briefly described as well as detailed data from recently published three big randomized trials (CONTRAST, Turkish on-line HDF and ESHOL). Being different in primary outcomes, all RCT demonstrated in the post hoc analysis that benefits in hard outcomes received patients with convection volumes greater than 20-24 l/session. The obtaining of such volumes requires resolving issues with hemoconcentration along the dialyzer. The role of HDF in RRT will be defined more exactly in evaluation of its efficiency and cost-efficiency in comparison with other methods of dialysis safety, tolerability and efficacy improvement.

About the Authors

A. Yu. Zemchenkov
City Mariinsky hospital - City nephrology center; I.I. Mechnikov North-West State medical university
Russian Federation


R. P. Gerasimchuk
City Mariinsky hospital - City nephrology center
Russian Federation


A. B. Sabodash
B. Braun Avitum Russland Clinics - Nevsky nephrology center
Russian Federation


References

1. Бикбов Б.Т., Томилина Н.А. Состояние заместительной терапии больных с хронической почечной недостаточностью в Российской Федерации в 1998-2009 гг. (Отчет по данным Российского регистра заместительной почечной терапии) // Нефрология и диализ. 2011. Т. 13. № 2. С. 150-264.

2. Вишневский К.А., Земченков А.Ю., Комашня А.В. и др. Физические нагрузки во время сеанса: комплаентность и эффекты // Нефрология и диализ. 2009. Т. 11. № 4. С. 302-309.

3. Вишневский К.А., Герасимчук Р.П., Земченков Г.А. и др. Возможности оценки статуса гидратации у диализных пациентов при помощи контроля изменения объема крови и мультичастотной биоимпедансометрии // Нефрология. 2013, в печати.

4. Дудко М.Ю., Шутов Е.В., Капитанов Е.Н., Ермоленко В.М. Влияние нарушений водного баланса на состояние сердечно-сосудистой системы у больных на заместительной почечной терапии // Нефрология и диализ. 2006. Т. 8. № 3. P. 244-249.

5. Рахматуллина Л.Н., Гуревич К.Я. Состояние водного статуса у больных, получающих различные виды заместительной почечной терапии // Нефрология и диализ. 2013. Т. 15. № 1. С. 74-86.

6. Смирнов А.В., Нестерова О.Б., Голубев Р.В. и др. Кардиопротективные эффекты сукцинат-содержащего диализирующего раствора // Нефрология. 2012. Т. 16. № 2. С. 69-78.

7. Строков А.Г., Терехов В.А., Гаврилин В.А., Поз Я.Л. Интрадиализная артериальная гипотензия и ее профилактика при помощи мониторинга относительного объема крови: Обзор литературы // Нефрология и диализ. 2010. Т. 12. № 4. С. 250-253.

8. Строков А.Г., Поз Я.Л., Гаврилин В.А. и др. Биоимпедансный анализ в практике программного гемодиализа: Краткий обзор литературы и собственный опыт диализного центра// Вестник трансплантологии и искусственных органов. 2012. Т. XIV. № 1. С. 59-65.

9. Строков А.Г., Поз Я.Л., Крышин К.Н. Управление термальным балансом с целью профилактики интрадиализной гипотензии // Вестник трансплантологии и искусственных органов. 2012. Т. XIV. № 4. С. 59-64.

10. Ягудина Р.И., Куликов А.Ю., Литвиненко М.М. QALY: история, методология и будущее метода // Фармакоэкономика. 2010. Т. 3. № 1. С. 7-11.

11. Akoglu H., Dede F., Piskinpasa S. et al. Impact of Low- or High-Flux Haemodialysis and Online Haemodiafiltration on Inflammatory Markers and Lipid Profile in Chronic Haemodialysis Patients // Blood Purif. 2013. Vol. 35 (4). P. 258-264.

12. Arnold R., Pussell B.A., Pianta T.J. et al. Effects of hemodiafiltration and high flux hemodialysis on nerve excitability in end-stage kidney disease // PLoS One. 2013. Vol. 8 (3): e59055.

13. Canaud B., Bragg-Gresham J.L., Marshall M.R. et al. Mortality risk for patients receiving hemodiafiltration versus hemodialysis: European results from the DOPPS // Kidney Int. 2006. Vol. 69 (11). P. 2087-2093.

14. Canaud B., Lertdumrongluk P. Ultrapure Dialysis Fluid: A New Standard for Contemporary hemodialysis // Nephro-Urol. Mon. 2012. Vol. 4 (3). P. 519-523.

15. Czifra A, Pa ll A, Kulcsa r J. et al. Hemodialysis and hemodiafiltration differently modulate left ventricular diastolic function // BMC Nephrol. 2013. Vol. 14. P. 76.

16. Eknoyan G., Beck G.J., Cheung A.K. et al. Effect of dialysis dose and membrane flux in maintenance hemodialysis // N. Engl. J. Med. 2002. Vol. 347 (25). P. 2010-2019.

17. Feliciani A., Riva M.A., Zerbi S. et al. New strategies in haemodiafiltration (HDF): prospective comparative analysis between on-line mixed HDF and mid-dilution HDF // Nephrol. Dial. Transplant. 2007. Vol. 22 (6). P. 1672-1679.

18. Fry A.C., Singh D.K., Chandna S.M. et al. Relative importance of residual renal function and convection in determining beta-2-microglobulin levels in high-flux haemodialysis and on-line haemodiafiltration // Blood Purif. 2007. Vol. 25 (3). P. 295-302.

19. Grooteman M.P., van den Dorpel M.A., Bots M.L. et al. Effect of online hemodiafiltration on all-cause mortality and cardiovascular outcomes (CONTRAST) // J. Am. Soc. Nephrol. 2012. Vol. 23 (6). P. 1087-1096.

20. Hakim R.M., Held P.J., Stannard D.C. et al. Effect of the dialysis membrane on mortality of chronic haemodialysis patients // Kidney Int. 1996. Vol. 50. P. 566-570.

21. Hornberger J.C., Chernew M., Petersen J., Garber A.M. A multivariate analysis of mortality and hospital admissions with high flux dialysis // J. Am. Soc. Nephrol. 1992. Vol. 3. P. 1227-1237.

22. http://clinicaltrials.gov/ct2/show/NCT00411177; accessed 06.08.13.

23. http://clinicaltrials.gov/ct2/show/NCT01327391; accessed06.08.13.

24. http://www.clinicaltrials.gov/show/NCT01693354, accessed 06.08.13.

25. http://clinicaltrials.gov/ct2/show/NCT01862679, accessed 06.08.13.

26. http://clinicaltrials.gov/ct2/show/NCT01877499; accessed 06.08.13.

27. Kumar S., Khosravi M., Massart A. et al. Haemodiafiltration results in similar changes in intracellular water and extracellular water compared to cooled haemodialysis // Am. J. Nephrol. 2013. Vol. 37 (4). P. 320-324.

28. Leypoldt J.K., Cheung A.K., Carroll C.E. et al. Effect of dialysis membranes and middle molecule removal on chronic hemodialysis patient survival // Am. J. Kidney Dis. 1999. Vol. 33: P. 349-355.

29. Locatelli F., Marcelli D., Conte F. et al. Registro Lombardo Dialisi e Trapianto. Comparison of mortality in ESRD patients on convective and diffusive extracorporeal treatments // Kidney Int. 1999. Vol. 55: P. 286-293.

30. Locatelli F., Mastrangelo F., Redaelli B. et al. Effects of different membranes and dialysis technologies on patient treatment tolerance and nutritional parameters. The Italian Cooperative Dialysis Study Group // Kidney Int. 1996. Vol. 50 (4). P. 1293-1302.

31. Locatelli F., Altieri P., Andrulli S. et al. Hemofiltration and hemodiafiltration reduce intradialytic hypotension in ESRD // J. Am. Soc. Nephrol. 2010. Vol. 21. P. 1798-1807.

32. Locatelli F. Dose of dialysis, convection and haemodialysis patients outcome - what the HEMO study doesn't tell us: the European viewpoint // Nephrol. Dial. Transplant. 2003. Vol. 18 (6). P. 1061-1065.

33. Locatelli F., Martin-Malo A., Hannedouche T. et al. Effect of membrane permeability on survival of hemodialysis patients // J. Am. Soc Nephrol. 2009. Vol. 20. P. 645-654.

34. Maduell F., Moreso F., Pons M. et al. High-efficiency postdilution online hemodiafiltration reduces all-cause mortality in hemodialysis patients // J. Am. Soc. Nephrol. 2013. Vol. 24 (3). P. 487-497.

35. Maheshwari V., Samavedham L., Rangaiah G.P. et al. Comparison of toxin removal outcomes in online hemodiafiltration and intra-dialytic exercise in high-flux hemodialysis: a prospective randomized open-label clinical study protocol // BMC Nephrol. 2012. Vol. 13.P. 156.

36. Mazairac A.H., Blankestijn P.J., Grooteman M.P. et al. The cost-utility of haemodiafiltration versus haemodialysis in the Convective Transport Study // Nephrol. Dial. Transplant. 2013. Vol. 28 (7). P. 1865-1873.

37. Mazairac A.H., de Wit G.A., Grooteman M.P. et al. Effect of hemodiafiltration on quality of life over time // Clin. J. Am. Soc. Nephrol. 2013. Vol. 8 (1). P. 82-89.

38. Ok E., Asci G., Toz H. et al. Mortality and cardiovascular events in online haemodiafiltration (OL-HDF) compared with high-flux dialysis: results from the Turkish OL-HDF Study // Nephrol. Dial. Transplant. 2013. Vol. 28 (1). P. 192-202.

39. Okuno S., Ishimura E., Kohno K. et al. Serum beta2-microglobulin level is a significant predictor of mortality in maintenance haemodialysis patients // Nephrol. Dial. Transplant. 2009. Vol. 24 (2). P. 571-577.

40. Pedrini L.A., Feliciani A., Zerbi S. et al. Optimization of mid-dilution haemodiafiltration: technique and performance // Nephrol. Dial. Transplant. 2009. Vol. 24 (9). P. 2816-2824.

41. Penne E.L., Visser L., van den Dorpel M.A. et al. Microbiological quality and quality control of purified water and ultrapure dialysis fluids for online hemodiafiltration in routine clinical practice // Kidney Int. 2009. Vol. 76 (6). P. 665-672.

42. Penne E.L., Van der Weerd N.C., Bots M.L. et al. on behalf of theCONTRAST investigators. Patient- and treatment-related determinants of convective volume in post-dilution haemodiafiltration in clinical practice // Nephrol. Dial. Transplant. 2009. Vol. 24 (11). P. 3493-3499.

43. Port F.K., Wolfe R.A., Hulbert-Shearon T.E. et al. Mortality risk by hemodialyzer reuse practice and dialyzer membrane characteristics: results from the USRDS dialysis morbidity and mortality study // Am. J. Kidney Dis. 2001. Vol. 37 (2). P. 276-286.

44. Rabin R., de Charro F. EQ-5D: a measure of health status from the EuroQol Group // Ann. Med. 2001. Vol. 33 (5). P. 337-343.

45. Rabindranath K.S., Strippoli G.F., Daly C. et al. Haemodiafiltration, haemofiltration and haemodialysis for end-stage kidney disease // Cochrane Database Syst. Rev. 2006. Vol. 18 (4).CD006258.

46. Ronco C. Hemodiafiltration and hemodialysis: clinical, financial and geographical issues // ISN World Congress of Nephrology. Hong Kong. June 3.2013.

47. Santoro A., Mancini E., Bolzani R. et al. The effect of on-line high-flux hemofiltration versus low-flux hemodialysis on mortality in chronic kidney failure: a small randomized controlled trial // Am. J. Kidney Dis 2008. Vol. 52 (3). P. 507-518.

48. Schiffl H. Prospective randomized cross-over long-term comparison of online haemodiafiltration and ultrapure high-flux haemodialysis // Eur. J. Med Res. 2007. Vol. 12 (1). P. 26-33.

49. Takemoto Y., Naganuma T. The economic issue of on-line hemodiafiltration within the J. apanese medical reimbursement system // Blood Purif. 2013. Vol. 35. Suppl 1. P. 74-76.

50. Vaithilingam I., Polkinghorne K.R., Atkins R.C., Kerr P.G. Time and exercise improve phosphate removal in hemodialysis patients // Am. J. Kidney Dis. 2004. Vol. 43 (1). P. 85-89.


Review

For citations:


Zemchenkov A.Yu., Gerasimchuk R.P., Sabodash A.B. Hemodiafiltration: attention on the volume Review. Nephrology and Dialysis. 2014;16(1):128-138. (In Russ.)

Views: 46


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1680-4422 (Print)
ISSN 2618-9801 (Online)